🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK239512 is being developed for the treatment of symptoms of cognitive imp...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00474513
Treatments Being Tested
This clinical study, titled "Head-to-Head Comparison Study between Differen...
Status
Completed
Location
QHS Health center
Start Date
2025-11-12
Trial ID
NCT07400718
The goal of this clinical trial is to determine whether topical tripelennam...
Status
Completed
Location
Palm Beach Atlantic University
Start Date
2025-02-24
Trial ID
NCT07778472
Treatments Being Tested
The primary objective of this study is to evaluate histamine, CGRP and VIP ...
Status
Completed
Location
Clinvest, Inc.
Start Date
2004-05
Trial ID
NCT00208065
Treatments Being Tested
Purpose and Hypotheses The purpose of this study is to find out if changing...
Status
Recruiting
Location
Faculty of Physical Therapy, Cairo University
Start Date
2026-08-01
Trial ID
NCT07736651
The objective of this study is to determine the biologic activity of a Chen...
Status
Completed
Location
Hospital General de Elche
Start Date
2012-11
Trial ID
NCT01675349
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
Aim of this study is to use the major allergen 1 of birch-tree pollen (Bet ...
Status
Completed
Location
Medical University of Vienna
Start Date
2011-02
Trial ID
NCT02098551
Treatments Being Tested
To evaluate the inter-arm and inter-period reproducibility of the dermal bl...
Status
Completed
Location
Center for Clinical Pharmacology
Start Date
2019-02-28
Trial ID
NCT04396977
Treatments Being Tested
* The study primary end point is the decrease in the number of monthly heav...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02800083
Treatments Being Tested